ContractdiaDexus, Inc. • November 7th, 2012 • Pharmaceutical preparations • California
Company FiledNovember 7th, 2012 Industry JurisdictionTHIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS, AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 4 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO RULE 144 OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
diaDexus, Inc. AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • November 7th, 2012 • diaDexus, Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 7th, 2012 Company Industry JurisdictionThis AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Agreement”) is entered into as of September 11, 2012, by and between Comerica Bank (“Bank”) and diaDexus, Inc. (“Borrower”).
Volume Discount Program AddendumPurchase Agreement • November 7th, 2012 • diaDexus, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 7th, 2012 Company IndustryThis Volume Discount Program Addendum to the Purchase Agreement (the “Addendum”) is effective as of August 20, 2012 (the “Addendum Effective Date”), by and between diaDexus, Inc. (“diaDexus”), and Atherotech Diagnostics Lab located at 201 London Parkway, Birmingham, AL 35211 and any or all of its subsidiaries or affiliates (“Lab”).
PURCHASE AGREEMENT – KIT PURCHASESPurchase Agreement • November 7th, 2012 • diaDexus, Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 7th, 2012 Company Industry JurisdictionThis Purchase Agreement between diaDexus, Inc. located at 349 Oyster Point Blvd, South San Francisco, CA 94080 (“diaDexus”) and Atherotech Diagnostics Lab located at 201 London Parkway, Birmingham, AL 35211 and any or all of its subsidiaries or affiliates (“Lab”), sets forth the terms and conditions upon which diaDexus will sell to Lab, and Lab will purchase, various products (the “Agreement”). As of August 20, 2012 (“Effective Date”) the parties agree as follows: